Alex N Bullock

30PUBLICATIONS
152CO-AUTHORS
Molecular targetsTumour immunologyBiologically active moleculesGlobal and planetary environmental engineeringProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 04, 2026
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders.

|Mar 09, 2026
Ubiquitin E3 ligase KLHL6 brings exhausted T-cells back into action.

Zhuoyao Chen, Alex N Bullock, Benedikt M Kessler

|Aug 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction.

Chunyu Lin, Dilip Narayanan, Marilia Barreca

|Apr 02, 2025
Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment.

Zhuoyao Chen, Gamma Chi, Timea Balo

|Dec 02, 2024
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the open.

Claudia Tredup, Suzanne Ackloo, Hartmut Beck

|Nov 21, 2024
Covalent Inhibitors of KEAP1 with Exquisite Selectivity.

Imre Fejes, Piroska Markacz, Janos Tatai

Pageof 5

Frequent Collaborators

6 joint publications

Stefan Knapp

4 joint publications

David H Drewry

4 joint publications

Zhuoyao Chen

3 joint publications

David Smil